• Schriftgröße:
  • Schriftgröße 1
  • Schriftgröße 2
  • Schriftgröße 3
  • Schriftgröße 4
  • Schriftgröße 5
Prof. Dr. C. Hamm

prof. hamm 11 web

Prof. Dr. med. Christian Hamm

Implantation eines Mitraclips

Implantation eines Mitraclips

Guidelines & Abstracts

Guidelines

  1. Hamm CW, Bösenberg H, Brennecke R et al: Leitlinien zur Einrichtung und zum Betreiben von Herzkatheterräumen (1. Neufassung). Z Kardiol 90: 367-376, 2001
  2. Bertrand ME, Simoons ML, Fox KAA, Wallentin LC, Hamm CW et al, for the Task Force of the ESC: Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 23; 1809-1840, 2002
  3. Hamm CW, Arntz H-R, Bode C, Giannitsis E, Katus H, Levenson B, Nordt Th, Neumann FJ, Tebbe U, Zahn R: Leitlinien: Akutes Koronarsyndrom (ACS). Teil 1: ACS ohne persistierende ST-Hebung. Z Kardiol 93: 72-90, 2004
  4. Hamm CW, Arntz H-R, Bode C, Giannitsis E, Katus H, Levenson B, Nordt Th, Neumann FJ, Tebbe U, Zahn R: Leitlinien: Akutes Koronarsyndrom (ACS). Teil 2: ACS mit ST-Hebung. Z Kardiol 93: 324-341, 2004
  5. Vogt A, Albrecht A, Breithardt G, Brennecke R, Fetsch T, Hamm CW, Haude M, Leuner C, Schneider S, Silber S, Zeymer U: Positionspapier zur Qualitätssicherung in der invasiven Kardiologie. Sind Mindestmengen bei perkutaner Koronarangioplastie evidenzbasiert? Z Kardiol 93: 829-833, 2004
  6. Silber S, Albertsson P, Aviles FF, Gamici PG, Colombo A, Hamm C et al: Guidelines for percutaneous coronary interventions. Eur Heart J 26: 804-847, 2005
  7. Bassand JP, Danchin N, Filippatos G, Gitt A, Hamm C, Silber S, Tubaro M, Weidinger F: Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Eur Heart J 26: 2733-2741, 2005
  8. Bassand JP, Hamm CW, Ardissino D et al., for the Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology: Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 28: 1598-1660, 2007
  9. Thygesen K, Alpert JS, White HD, CW Hamm et al., on behalf of the Joint ESC/ACCF/AHA/WHF Task Force: Universal definition of myocardial infarction. Eur Heart J 28: 2525-2538, 2007
  10. Thygesen K, Alpert JS, White HD, CW Hamm et al., on behalf of the Joint ESC/ACCF/AHA/WHF Task Force: Universal definition of myocardial infarction. Circulation 116: 2634-2653, 2007
  11. Hamm CW, Albrecht A, Bonzel T, Kelm M, Lange H, Schächinger V, Terres W, Voelker W: Diagnostische Herzkatheteruntersuchung. Clinical Research in Cardiology: 97 (No. 8): 475-512, 2008
  12. Bonzel T, Erbel R, Hamm CW, Levenson B, Neumann FJ, Rupprecht HJ, Zahn R: Perkutane Koronarinterventionen (PCI). Clinical Research in Cardiology: 97 (No. 8): 513-547, 2008

Abstracts

Bisher sind seit 1978 572 Abstracts (wissenschaftliche Kurzfassungen) veröffentlicht worden.

Veröffentlichungen seit 2003

  1. Kurzidim KW, Neumann T, Reinke H, Sperzel J, Bahavar H, Reiner C, HammCW, Pitschner HF: Optimization of cardiac resynchronization therapy by sequential biventricular stimulation: results of an acute hemodynamic study. JACC 41 (Suppl A): 173A, 2003
  2. Kurzidim KW, Neumann T, Reinke H, Sperzel J, Siemon G, Reiner C, Bahavar H, Hamm CW, Pitschner HF: Isolated left ventricular pacing is superior to biventricular pacing in patients with normal PQ-time. JACC 41 (Suppl A): 174A, 2003
  3. Brandt RR, Reiner C, Sperzel J, Pitschner HF, Hamm CW: Contractile response and mitral regurgitation after late withdrawal of biventricular pacing. JACC 41 (Suppl A): 176A, 2003
  4. Ekinci O, Dill T, Neumann T, Maksimovic R, Brandt RR, Rau M, Weber MW, Hamm CW: Diagnostic value of magnetic resonance imaging in patients with atrial septal defect in comparison to heart catheterization and transesophageal echocardiography. JACC 41 (Suppl A): 439A, 2003
  5. Hamm C: Therapie der Herzinsuffizienz. Antikoagulation oder Thrombozytenaggregationshemmung. Med Klin 98: V380, 2003
  6. Hamm CW, Senges J, für das Cypher Stent Register: Erste Ergebnisse des deutschen Drug-eluting Stent Registers. Z Kardiol 92 (Suppl 1): I/1, 2003
  7. Mitrovic V, Dill T, Weber M, Anand I, Notter T, Schenk J, Bankovic D, Hamm CW: Vergleich der diagnostischen und prognostischen Bedeutung von NT-pro BNP mit BNP bei Patienten mit Herzinsuffizienz. Z Kardiol 92 (Suppl 1): I/21, 2003
  8. Ekinci O, Dill T, Kuniss M, Rad A, Hamm CW: Erfassung von Pulmonalvenenstenosen nach HF-Stromkatheterablation bei Vorhofflimmern in einer Langzeitbeobachtung mittels Magnetresonanz-Angiographie. Z Kardiol 92 (Suppl 1): I/228, 2003
  9. Heeschen C, Hamm CW, Zeiher AM: CD40 Ligand Serumspiegel bei Patienten mit akuten Thoraxschmerzen identifizieren schnell und zuverlässig Hochrisiko-Patienten mit akutem Koronarsyndrom. Z Kardiol 92 (Suppl 1): I/258, 2003
  10. Heeschen C, Hamm CW, Mitrovic V: N-terminales Pro-B-Typ natriuretisches Peptid ist ein unabhängiger prognostischer und diagnostischer Indikator bei Patienten mit akutem Koronarsyndrom ohne ST-Hebungen. Z Kardiol 92 (Suppl 1): I/259, 2003
  11. Brandt R, Reiner Chr, Sperzel J, Hamm CW: Hämodynamische Effekte nach Unterbrechung einer chronischen kardialen Resynchronisationstherapie. Z Kardiol 92 (Suppl 1): I/316, 2003
  12. Rau M, Weber M, , Neumann T, Maikowski Chr, Keil E, Brandt R, Mitrovic V, Hamm CW: Ergospirometrische Evaluation der kardialen Leistungsverbesserung nach interventionellem ASD-Verschluss im Langzeitverlauf. Z Kardiol 92 (Suppl 1): I/410, 2003
  13. Hamm CW: Certification for special expertise: improving the quality of care or fragmenting cardiology? Interventional cardiology. Z Kardiol 92 (Suppl 1): I/248, 2003
  14. Hamm CW: Eine neue Kontroverse? Aspirin in der Behandlung der koronaren Herzkrankheit (pro). Z Kardiol 92 (Suppl 1): I/362
  15. Ekinci O, Dill T, Neumann T, Hansel J, Kluge A, Bachmann G, Pitschner HF, Hamm CW: Detection of pulmonary vein stenoses after radiofrequency catheter ablation in patients with atrial fibrillation using magnetic resonance imaging: a long-term follow-up. Eur Heart J 24 (Suppl): 4, 2003
  16. Dietz U, Baldus S, Rupprecht H-J, Küchler R, Vom Dahl J, Hamm CW: Impact of stenting on angiographic outcome in multivessel disease (GABI II study) and comparison with results of the GABI trial. Eur Heart J 24 (Suppl): 85, 2003
  17. Hamm C, Senges J, on behalf of the Terman CYPHER stent regystry: Initial results of the German drug-eluting stent registry. Eur Heart J 24 (Suppl): 429, 2003
  18. Rau M, Maikowski C, Weber M, Zahn R, Schneider S, Senges J, Hamm C, on behalf of the Terman CYPHER stent regystry. Eur Heart J 24 (Suppl): 431, 2003
  19. Dill T, Ekinci O, Weber M, Hansel J, Rau M, Mueller KD, Hamm CW: Diagnostic value of adenosine stress magnetic resonance imaging in comparison to 201TI single-photon emission computed tomography myocardial scintigraphy and coronary angiography for detection of coronary artery disease and myocardial scar tissue. Eur Heart J 24 (Suppl): 440, 2003
  20. Hamm CW: Acute coronary syndromes: the role of troponins? Clinical Chemistry and Laboratory Medicine 41: A79, 2003
  21. Hamm C: Die instabile Angina pectoris (IAP) nach neuer Klassifikation: Welche Diagnostik – welche Therapie? Z Kardiol 92 (Suppl 2): II/36 (2003)
  22. Baldus S, Meinertz T, Eiserich JP, Münzel T, CW Hamm: Myoeloperoxidase serum levels predict the risk of patients with acute coronary syndromes. Circulation 108 (Suppl): IV-377, 2003
  23. Dill T, Ekinci O, Hansel J, Weber M, Rau M, Kluge A, Bachmann G, Hamm CW: The diagnostic value of adenosine stress MRI in the routine clinical setting compared to SPECT and coronary angiography. Circulation 108 (Suppl): IV-402, 2003
  24. Heeschen C, Fichtlscherer S, Hamm CW, Simoons ML, Zeiher AM: Placental growth factor: a novel serum marker of vascular inflammation predicting the risk of patients with acute coronary syndromes. Circulation 108 (Suppl): IV-469, 2003
  25. Heeschen C, Fichtlscherer S, Hamm CW: Pregnancy-associated plasma protein-A (PAPP-A) plasma level independently predict outcome in troponin negative patients with acute coronary syndromes. Circulation 108 (Suppl): IV-470, 2003
  26. Weber MW, Arnbold R, Rau M, Maikowski C, Keil E, Mitrovic V, Brandt R, Hamm C: N-terminal pro braintype natriuretic peptide (NT-proBNP) is a highly sensitive biochemical marker for surgical therapy in patients with aortic stenosis. Circulation 108 (Suppl): IV-513, 2003
  27. Hamm CW, Schneider S, Senges J, for the German CYPHER stent registry. Initial results of the German drug-eluting stent registry. Circulation 108 (Suppl): IV-533, 2003
  28. Mitrovic V, Anand I, Dill T, Weber M, Notter T, Schenk J, Luescher TF, Hamm CW: Nonterminal pro B-type natriuretic peptide in patients with chronic heart failure: correlation with B-type natriuretic peptide and left ventricular structure and function. JACC 43 (Suppl A): 235A, 2004
  29. Ekinci O, Dill T, Hansel J, Kluge A, Weber M, Bachmann G, Hamm CW: Diagnostic value of adenosine stress magnetic resonance (MR) perfusion imaging and delayed MR hyperenhancement compared to TI-201 SPECT and coronary angiography for detection of coronary artery disease and myocardial scar tissue. JACC 43 (Suppl A): 354A, 2004
  30. Weber MW, Arnold R, Rau M, Maikowski C, Keil E, Brandt R, Mitrovic V, Hamm C: N-terminal pro-braintype natriuretic peptide in patients with aortic valve disease: correlation to surgical result. JACC 43 (Suppl A): 436A, 2004
  31. Weber MW, Arnold R, Dill T, Rau M, Mitrovic V, Mueller KD, Hamm C: N-terminal-pro braintype natriuretic peptide predicts extent of coronary artery disease and myocardial ischemia in patients with stable angina pectoris. JACC 43 (Suppl A): 292A, 2004
  32. Kaehler J, Koester R, Rupprecht HJ, Ischinger T, Jahns R, Vogt A, Lampen M, Hoffmann R, Meinertz T, Hamm CW: 13-year follow-up of the German angioplasty surgery investigation. JACC 43 (Suppl A): 80A, 2004
  33. Rau M, Maikowski Chr, Weber M, Elsässer A, Schneider S, Hamm C: Behandlung von in-Stent Restenosen durch Drug-Eluting-Stents. Daten aus dem deutschen Cypher-Stent Register. Z Kardiol 93 (Suppl 3): III/16, 2004
  34. Weber M, Arnold R, Rau M, Maikowski Chr, Keil E, Mitrovic V, Brandt R, Hamm C: N-terminales B-Typ natriuretisches Peptid (NT-proBNP) bei Patienten mit Aortenklappenerkrankungen in Relation zum klinischen Verlauf. Z Kardiol 93 (Suppl 3): III/47, 2004
  35. Dill T, Klein P, Hansel J, Ekinci O, Rad A, Mitrovic V, Hamm C: Darstellung atherosklerotischer Plaques in der Arteria carotis mittels hochauflösender MRT im zeitlichen Verlauf vor und nach hochdosierter Atorvastatin-Therapie. Z Kardiol 93 (Suppl 3): III/48, 2004
  36. Hamm C: Was können Neurologen lernen aus den Erfahrungen der Kardiologen mit GP-IIb-IIIa-Antagonisten? Z Kardiol 93 (Suppl 3): III/80, 2004
  37. Levenson B, Bonzel T, Hamm C, Kelm M, Nienaber Chr, Richardt G, Schneider S, Sabin G, Senges J, Tebbe U; für das Deutsche Cypher-Register. Z Kardiol 93 (Suppl 3): III/87, 2004
  38. Kelm M, Schneider S, Senges J, Bonzel T, Tebbe U, Nienaber Chr, Levenson B, Sabin G, Hamm C; für das Deutsche Cypher-Register: Sicherheit und Erfolg der Implantation von Drug-Eluting Stents in koronarvenösen Bypässen. Z Kardiol 93 (Suppl 3): III/87, 2004
  39. Kähler J, Köster R, Rupprecht HJ, Ischinger T, Jahns R, Vogt A, Lampen M, Hoffmann R, Hamm CW; für the German Angioplasty Bypass Surgery Investigation: 13-year follow-up of the German Angioplasty Bypass Surgery Investigation (GABI). Z Kardiol 93 (Suppl 3): III/117, 2004
  40. Maikowski Chr, Rau M, Weber M, Keil E, Elsässer A, Hamm C: Behandlung von komplexen In-Stent Restenosen (ISR) mit Sirolimus Drug Eluting Stents (DES). Z Kardiol 93 (Suppl 3): III/187, 2004
  41. Rau M, Weber M, Keil E, Maikowski Chr, Elsässer A, Hamm C: Implementierung eines Herzinfarkt Netzwerkes zur Optimierung der Zeiten bis zur Akutrekanalisation nach Leitlinien. Z Kardiol 93 (Suppl 3): III/250, 2004
  42. Hamm C: Diagnostic strategy in ACS – the German view. Z Kardiol 93 (Suppl 3): III/272, 2004
  43. Heeschen Chr, Hamm CW, Fichtlscherer S, Simoons ML; for the C7E3 Anti Platelet Therapy in Unstable Refractory angina Study Investigators: Pregnancy-associated plasma protein-A (PAPP-A) ist ein unabhängiger Prädiktor bei Patienten mit akutem Koronarsyndrom ohne Tropoonin Anstieg. Z Kardiol 93 (Suppl 3): III/381, 2004
  44. Heeschen Chr, Hamm CW, Fichtlscherer S, Berger J, Simoons ML, Zeiher AM; for the C7E3 Anti Platelet Therapy in Unstable Refractory angina Study Investigators: Risikostratifizierung von Patienten mit akutem Koronarsyndrom – brauchen wir Multimarkermessungen? Z Kardiol 93 (Suppl 3): III/382, 2004
  45. Brandt R, Arnold R, Rau M, Neumann T, Mitrovic V, Hamm C: Reverses Remodeling des rechten Herzens nach interventionellem ASD Verschluß. Z Kardiol 93 (Suppl 3): III/426, 2004
  46. Mitrovic V, Anand I, Dill T, Weber M, Notter T, Schenk J, Lüscher T, Hamm C: Diagnostic and prognostic value of NT-pro BNP in patients with chronic heart failure. Correlation with hemodynamics. Z Kardiol 93 (Suppl 3): III/448, 2004
  47. Ekinci O, Dill T, Hansel J, Kluge A, Bachmann G, Hamm CW: Detection of intraventricular thrombi by contrast enhanced magnetic resonance imaging of the heart. Eur Heart J 25 (suppl): 43, 2004
  48. Ekinci O, Dill T, Hansel J, Greiss H, Pitschner HF, Hamm CW: 16-slice multi-detector computed tomography for evaluation of stent patency in pulmonary veins of patients with acquired pulmonary vein stenosis following radiofrequency catheter ablation. Eur Heart J 25 (suppl): 70, 2004
  49. Dill T, Ekinci O, Hansel J, Klein PS, Rad A, Mitrovic V, Hamm CW: High resolution magnetic resonance imaging of human atherosclerotic carotid lesions before and after six months of high dose atorvastatin therapy. Eur Heart J 25 (suppl): 146, 2004
  50. Dill T, Ekinci O, Hansel J, Weber M, Kluge A, Bachmann G, Hamm CW: Adenosine stress magnetic resonance perfusion compared to 201TI-SPECT and coronary angiography for the detection of coronary artery disease and myocardial infarction in 92 patients. Eur Heart J 25 (suppl): 335, 2004
  51. Maikowski C, Rau M, Weber M, Keil E, Elsaesser A, Hamm C: Sirolimus drug-eluting stent for the treatment of in-stent restenosis with a clinical and angiographical follow-up over 6 months. Eur Heart J 25 (suppl): 670, 2004
  52. Maikowski C, Weber M, Rau M: Patients with in-stent-restenosis (I-SR) treated with Sirolimus-coated drug-eluting stents. Circulation (Suppl III) 110: III-406, 2004
  53. Dill T, Deetjen A, Klein PS, Ekinci O, Hansel J, Mitrovic V, Hamm CW: High-resolution magnetic resonance imaging of human atherosclerotic carotid lesions before and after six months of high-dose atorvastatin therapy. Circulation (Suppl III) 110: III-686, 2004
  54. Weber M, Elsaesser A, Kleine C, Keil E, Rau M, Maikowski C, Mitrovic V, Hamm C: NT-proBNP is strongly related to the TIMI risk score in ACS. JACC 45 (Suppl A): 214A, 2005
  55. Rau M, Weber M, Elsaesser A, Keil E, Maikowski C, Hamm C: Time to treatment of acute myocardial infarction (AMI) can be optimized by an integrated infarction network according to guidelines. JACC 45 (Suppl A): 226A, 2005
  56. Hamm CW: Novel inflammatory markers in acute coronary syndromes (ACS). Circulation Journal. Official Journal of the Japanese Circulation Society. Vol. 69 (suppl I): 47, 2005
  57. Ekinci O, Berkowitsch A, Neumann T, Greiss H, Pitschner HF, Hamm CW, Dill T: Pulmonary vein diameter reduction observed in early magnetic resonance angiography after radiofrequency ablation: prognostic significance for development of severe stenosis. Eur Heart J 26 (Abstract Suppl): 97, 2005
  58. Ekinci O, Dill T, Rad A, Hansel J, Rau M, Bachmann G, Hamm CW: Complementary use of adenosine stress perfusion MRI and multislice CT coronary angiography for detection of haemodynamically significant coronary artery disease. Eur Heart J 26 (Abstract Suppl): 98, 2005
  59. Pitschner HF, Reddy V, Kuniss M, Neuzil P, Laragy M, Taborsky M, Ruskin J, Hamm C: Pulmonary vein isolation in patients with atrial fibrillation using a novel balloon cryoablation catheter. Eur Heart J 26 (Abstract Suppl): 131, 2005
  60. Weber M, Kleine C, Keil E, Elsaesser A, Rau M, Berkowitsch A, Mitrovic V, Hamm C: Duration from onset of ymptoms is a major determinant for the elevation of NT-proBNP in acute coronary syndromes. Eur Heart J 26 (Abstract Suppl): 183, 2005
  61. Weber M, Arnold R, Elsaesser A, Brandt R, Mitrovic V, Hamm C: N-terminal pro B-type natriuretic peptide (NT-proBNP) is related to severity of chronic aortic regurgitation. Eur Heart J 26 (Abstract Suppl): 194, 2005
  62. Deetjen A, Moellmann S, Conradi G, Ekinci O, Hansel J, Kluge A, Hamm CW, Dill T: Multislice computed tomography of the coronaries: intraindividual comparison of radiation dose exposure with conventional coronary angiography. Eur Heart J 26 (Abstract Suppl): 437, 2005
  63. Lenderink T, Heeschen C, Fichtlscherer S, Dimmeler S, Hamm C, Zeiher A, Simoons M, Boersma E, on behalf of The CAPTURE investigators: Elevated placental growth factor levels are associated with adverse outcome at four year follow-up in patients with acute coronary syndromes. Eur Heart J 26 (Abstract Suppl): 651, 2005
  64. Geibel A, Hamm C, Bonzel T, Senges J, Bode C, Zehender M, on behalf of German Cypher-Registry. Gender differences in the outcome after sirolimus-eluting coronary stenting – results from the prospective multi-centre German Cypher Registry. Eur Heart J 26 (Abstract Suppl): 703, 2005
  65. 526. Willich SN, Brueggenjuergen B, McBride D, Bode C, Hamm CW, Kuck KH: Drug-eluting versus bare-metal stents for the reduction of coronary restenosis: outcome and economic analysis of a controlled study. Eur Heart J 26 (Abstract Suppl): 709, 2005
  66. Moellmann H, Kostin S, Nef H, von Kalle C, Pilz I, Hamm C, Schaper J, Elsaesser A: No evidence for differentiation of haematopoetic stem cells into cardiomyocytes after myocardial infarction. Eur Heart J 26 (Abstract Suppl): 727, 2005
  67. Möllmann H, Nef HM: Haematopoietic stem cells do not contribute to myocardial repair after myocardial infarction. Circulation 112 (Suppl II): II-226, 2005
  68. Hamm CW: Results of the DaVinci Registry: pushing bare metal stents to the limits. Circulation 112 (Suppl II): II-682, 2005
  69. Weber M, Dill T, Deetjen A: Left ventricular adaptation after ASD closure assessed by elevated levels of NT-proBNP and cardiac MRI. Circulation 112 (Suppl II): II-563, 2005
  70. Colombo A, Tsuchida K, Lefèvre T, Serruys P, Oldroyd K, Guetta V, Guagliumi G, von Scheidt W, Ruzyllo W, Hamm C: Efficacy of sirolimus-eluting stent in the treatment of patients with bifurcation lesions in multivessel coronary artery disease: a substudy of the Art II Trial. Circulation 112 (Suppl II): II-421, 2005
  71. Weber M, Hausen M, Arnold R, Berkowitsch A, Elsaesser A, Mitrovic V, Hamm C: Prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in conservatively treated patients with valvular aortic stenosis. JACC, February 21: 286A, 2006
  72. Möllmann H, Nef HM, Kostin S, Schaper J, Weber M, Hamm CW, Elsässer A: Bone marrow-derived cells do not transdifferentiate into cardiomyocytes after myocardial infarction. JACC, February 21: 158A, 2006
  73. Möllmann S, Deetjen A, Conradi G, Weber M, Hamm CW, Dill T: Intraindividual comparison of radiation dose exposure between multislice computed tomography and conventional coronary angiography: JACC, February 21: 128A, 2006
  74. Möllmann H, Nef H, Weber M, Hamm CW: BNP expression in ischemic myocardium. Circulation 114 (suppl): II-415, 2006
  75. Weber M, Kleine C, Stanisch M, Moellmann H, Nef H, Elsaesser A, Mitrovic V, Hamm C: Prognostic value of NT-proBNP assessment at admission in patients with acute coronary syndromes who are troponin T negative. Circulation 114 (suppl): II-417, 2006
  76. Willich SN, Bruggenjurgen B, McBride D, Bode C, Hamm C, Kuck KH: Sirolimus-eluting versus bare-metal stents fort he reduction of coronary restenosis: outcome and economic analysis of the GERSHWIN study. Circulation 114 (suppl): II-689, 2006
  77. Schächinger V, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey D, Hamm CW et al: Intracoronary infusion of bone-marrow-derived progenitor cells is associated with improved clinical outcome in patients with acute myocardial infarction: 12 months follow up of the REPAIR-AMI trial. Circulation 114 (suppl): II-787, 2006
  78. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hälschermann H, Yu J, Corti R, Mathey D, Hamm C et al.: Predictors of contractile recovery of left ventricular function after intracoronary infusion of bone-marrow-derived progenitor cells in patients with acute myocardial infarction: lessons from the REPAIR-AMI trial. Circulation 114 (suppl): II-788, 2006
  79. Dill T, Schaechinger V, Möllmann S, Rolf A, Hoelschermann HF, Thiele H, Zeiher A, Hamm CW: Left ventricular function after intracoronary infusion of bone marrow-derived progenitor cells after acute STEMI: MRI substudy of the double-blind, randomized, placebo-controlled multicenter REPAIR-AMI trial. Circulation 114 (suppl): II-806, 2006
  80. Dill T, Ekinci O, Weber M, Deetjen A, Conradi G, Hamm CW: Adenosin stress MR perfusion and MR viability imaging for detection of hemodynamically relevant coronary artery disease. A prospective study for comparison with perfusion scintigraphy and coronary angiography. Circulation 114 (suppl): II-807, 2006
  81. Nef HM, Mollmann H, Vogt A, Weber M, Deetjen A, Dill T, Brandt R, Hamm CW, Elsässer A: Multiple episodes of a transient global left ventricular dysfunction reminiscent to apical ballooning. Cardiology 108 (1): 1-3, 2007
  82. Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Alyward PE, Van de Werf F, Hamm CW, for the APEX-AMI Investigators: Time is muscle: delay in primary PCI results in larger infarct size by delaed enhancement cardiac magnetic resonance – Results from the APEX-AMI study. JACC 49 (suppl A): 125A, 2007
  83. Möllmann H, Nef HM, Weber M, Rau M, Hamm CW, Elsässer A: Outcome of patients after successful cardiopulmonary resuscitation and suspected acute coronary syndrome treated with an early invasive strategy. JACC 49 (suppl A): 228A, 2007
  84. Möllmann H, Nef HM, Troidl C, Voss S, Klement M, Hamm CW, Weber M, Kostin S, Elsässer A: Stem cell-mediated natural intraventricular tissue engineering. JACC 49 (suppl A): 222A, 2007
  85. Nef HM, Möllmann H, Troidl C, Wber M, Ogurek N, Dill T, Brandt R, Hamm CW, Elsässer A: Energy deprivation in apical ballooning as possible pathomechanism of contractile dysfunction and structural degeneration. JACC 49 (suppl A): 77A, 2007
  86. Nef HM, Troidl C, Möllmann H, Weber M, Ogurek N, Dill T, Brandt R, Hamm CW, Elsässer A: Expression of profiling of cardiac genes in Tako-tsubo cardiomyopathy: insight in a new cardiac entity. JACC 49 (suppl A): 77A, 2007
  87. Rolf A, Dill T, Moellmann S, Conradi G, Schaechinger V, Zeiher A, Hamm CW: One year follow-up of left ventricular function and remodeling after intracoronary infusion of bone marrow-derived progenitor cells after acute Stemi: MRI substudy of the double-blind, randomized placebo-controlled multicenter Repair-AMI trial. JACC 49 (suppl B): 22B, 2007
  88. O'Neill WO, Armstrong PW, Alkhalidi HR, Hamm CW et al: Blood transfusion is independently associated with death in acute myocardial infarction: insights from APEX-AMI (Assessment of Pexelizumab in Acute Myocardial Infarction) trial. JACC 49 (suppl B): 36B, 2007
  89. Serruys PW, Colombo A, Dawkins K, De Bruyne B, Hamm C et al: Arterial revacularization therapies study part II – Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions: three-year clinical outcomes. JACC 49 (suppl B): 45B, 2007
  90. Möllmann H, Nef H,… Hamm CW et al.: Bone marrow derived cells contribute to cell turnover in ageing murine hearts. Circulation 116 (no. 16): II-41, 2007
  91. Weber M, Keil E, … Hamm C: Gender is an important determinate fort he predictive value of NT-proBNP in patients presenting with an acute coronary syndrome. Circulation 116 (no. 16): II-576, 2007
  92. Weber M, Fichtlscherer S, … Hamm C: Prognostisc value of the soluble PIGF receptor sFlt-1 in patients presenting with an acute coronary syndrome. Circulation 116 (no. 16): II-578, 2007
  93. Weber MW, Fichtlscherer S, … Hamm C: The prognostic value of the Wnt antagonist Dickkopf-1 (dkk-1) in patients presenting with an acute coronary syndrome. Circulation 116 (no. 16): II-579, 2007
  94. Rixe J, Conradi G … Hamm C: Diagnostic accuracy of dual source-MDCT for detection of significant coronary artery stenoses in comparison to invasive coronary angiography. Circulation 116 (no. 16): II-692, 2007
  95. Assmus B, Schächinger V … Hamm CW: Intracoronary administration of bone marrow-derived progenitor cells abrogates progressive left ventricular enlargement after AMI: insights from the REPAIR-AMI trial. Circulation 116 (no. 16): II-756, 2007
  96. Schächinger V, Erbs S, … Hamm C, for the REPAIR-AMI investigators: Amelioration of early ventricular remodeling by intracoronary progenitor cell infusion in patients with AMI is associated with improved late clinical outcome. Circulation 116 (no. 16): II-762, 2007
  97. Rolf A, Möllmann S … Hamm C: Positive effect of bone marrow progenitor cell transfer on regional post infarction ventricular remodeling by magnetic resonance imaging. Insights from the REPAIR-AMI Trial. Circulation 116 (no. 16): II-772, 2007
  98. Schächinger V, Erbs S, …Hamm C, for the REPAIR-AMI investigators: Sustained 2 year clinical benefit from intracoronary infusion of bone marrow-derived progenitor cells in patients after acute myocardial infarction. Circulation 116 (no. 16): II-777, 2007
  99. Weber MW, Hamm CW, Bhatt DL et al: Low inflammatory activity evidenced by hsCRP predicts a benefit from clopidogrel treatment in patients with high risk for cardiovascular events. – A substudy from the CHARISMA Trial. Circulation 116 (no. 16): II-801, 2007
  100. Legrand VM, Daemen J, Morice M-C, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm CW et all: The Impact of Age on Outcomes After Percutaneous Coronary Intervention With or Without Drug Eluting Stents Versus Coronary Artery Bypass Surgery: Three-year Results From the Arterial Revascularization Therapies Study (ARTS) Part I and Part II. JACC 51 (suppl B): A265, 2008
  101. Theroux P, Armstrong PW, Moliterno DJ, Neumann F-J, Stebbins AL, Mahaffey KW, Hochman JS, Hamm CW et all: Do Selected Markers of Inflammatory Response During the Acute Phase of ST-Segment Elevation Myocardial Infarction Relate to Outcome? JACC 51 (suppl A): A185, 2008
  102. Bainey KR, Fu Y, Granger CB, Hamm CW et al: Impact of Spontaneous Reperfusion in Diabetics with Acute Myocardial Infarction. JACC 51 (suppl A): A203, 2008
  103. Rixe J, Dollas L, Rolf A, Conradi G, Bachmann G, Hamm CW, Dill T: Detection of Cardiac Allograft Vasculopathy Using Dual-Source MDCT With a Temporal Äresolution of 83 ms: Comparison to Quantitative Invasive Angiography. JACC 51 (suppl A): A144, 2008
  104. Van Domburg RT, Daemen J, Morice M-C, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm CW et all.: Short- and Long-term Health Related Quality of Life and Anginal Status in Patients Ireated for Multivessel Coronary Artery Disease: Insights Into the ARTS-II Trial. JACC 51 (suppl B): B19, 2008
  105. Heestermans AACM, van Werkum JW, ten Berg JM, Mosterd A, de Boer MJ, Gosselink AT, Dill T, van Houwelingen G, Hamm C et al: The effect of pre-hospital initiation of high dose bolus tirofiban in ST-segment elevation myocardial infarction on the incidence of complete ST-segment resolution before primary percutaneous coronary intervention: a sub-analysis of the On-TIME 2 Trial. JACC 53 (no. 10, suppl A): 1032-153-A330, 2009
  106. Welsh RC, Granger CB, Westerhout CM, Blankenship JC, Holmes DR, O'Neill WW, Hamm CW et al: Prior coronary artery bypass graft portends high risk in STEMI patients treated with primary percutaneous coronary intervention. JACC 53 (no. 10, suppl A): 1023-161-A322, 2009
  107. Bauer T, Hamm C, Zeymer U, Hochadel M, Eberli F, Seabra-Gomes R et al: Contemporary trends in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes: results from the Euro Heart Survey PCI Registry. JACC 53 (no. 10, suppl A): 1037-23-A393, 2009
  108. Kaul P, Granger CB, Armstrong PW, Bakal JA, Hamm CW et al: New insights into finding low-risk patients with ST-elevation myocardial infarction: the case for very early discharge. JACC 53 (no. 10, suppl A): 0919-5-A402, 2009
  109. Bauer T, Hamm C, gitt A, Möllmann H et al: Elective percutaneous coronary intervention in the elderly: lessons from the Euro Heart Survey PCI Registry. JACC 53 (no. 10, suppl A): 2520-788-A83, 2009
  110. Gitt AK, Bauer T, Zeymer U, Zahrt R, Hochadel M, Hamm C, Marco J: Impact of radial arterial access for PCI on bleeding complications in patients with acute coronary syndromes in clinical practice: results of the Euro Heart Survey PCI-Registry. JACC 56 (no 13, suppl B): TCT-511 / B117, 2010
  111. Gitt AK, Bauer T, Zahrt R, Zeymer U, Hochadel M, Hamm C, Marco J: Lower rate of major bleeding complications with radial arterial access for elective PCI in clinical practice in Europe: results oft he Euro Heart Survey PCI-Registry. JACC 56 (no 13, suppl B): TCT-513 / B117, 2010

© 2010-2024 Prof. Dr. C. Hamm